Mikra Launches New Immune Protect Gummies with Bundle Sales Promotion
TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), […]
GXO Honored as “Logistics Operator of the Year” in Italy
The award, given by Assologistica, recognizes People Care, a collection of Diversity & Inclusion initiatives TREZZO-SULL’ADDA, Italy, Dec. 20, 2023 […]
Winnebago Industries Reports First Quarter Fiscal 2024 Results
— Diversified Portfolio of Premium Products Demonstrates Continued Resilience in Challenging Market Environment —— Maintains Healthy Gross Profit Margins of […]
American Pacific Receives Permit To Drill High-Grade Madison Copper Gold Project In Montana
VANCOUVER, British Columbia, Dec. 20, 2023 (GLOBE NEWSWIRE) — American Pacific Mining Corp (CSE: USGD / OTCQX: USGDF / FWB: […]
Asensus Announces Sale of Senhance Robotic System in Romania
RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company […]
TSX News -
Aura Closes the Royalty Agreement and Gold-Linked Loan Agreement to Fund the Construction of the Borborema Project
ROAD TOWN, British Virgin Islands, Dec. 20, 2023 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: […]
Integra Submits Draft Mine Plan of Operations for the DeLamar Project
VANCOUVER, British Columbia, Dec. 20, 2023 (GLOBE NEWSWIRE) — Integra Resources Corp. (“Integra” or the “Company”) (TSXV: ITR; NYSE American: […]
CNH introduces agriculture’s first accessible tractor
Our photo series looks at how our New Holland brand launched this world-first in Brazil. Basildon, December 20, 2023 CNH […]
Himax to Present Innovative Solutions for tinyML Opportunities with WiseEye™ AI During CES 2024
TAINAN, Taiwan, Dec. 20, 2023 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and […]
argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus
ADDRESS study did not meet primary or secondary endpoints Pemphigus deprioritized as efgartigimod indication Update on BALLAD study GO/NO GO […]
